Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Synopsys, Inc. (SNPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Inverse MSTR Daily Target ETF vs Synopsys, Inc. — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.56 (market cap $94.46M), while Synopsys, Inc. trades at $507.55 (market cap $95.39B). The key difference: Synopsys, Inc. is far larger — about 1009.8× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Synopsys, Inc. is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Synopsys, Inc. for 71 Days on average.
| MSTZ | SNPS | |
|---|---|---|
Market Cap | $94.46M | $95.39B |
Volume | 104,717,733 | 3,374,903 |
Sector | Leveraged / Inverse | Technology |
52-Week High | $27.92 | $534.56 |
52-Week Low | $2.29 | $367.70 |
Typical Hold Time | 8 Days | 71 Days |
Enterprise Value | — | $102.62B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTZ is trading at $2.54, down 4.51% today, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks key financial ratio data, making fundamental assessment challenging. Recent ETF coverage highlights its inclusion in leveraged/inverse ETF discussions, though specific company performance details are limited.
The outlook remains cautious due to incomplete financial disclosures and bearish technical signals. Investment opportunities depend on forthcoming earnings clarity, while risks include volatility from limited institutional coverage and market sentiment shifts. Investors should await detailed financial updates for informed decisions.
Synopsys (SNPS) trades at $502.67, down 0.49% on the day, amid a bullish technical trend and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent news highlights AI-driven partnerships with OpenAI and Amazon, boosting growth prospects. Valuation ratios are elevated, with a P/E of 86.87, reflecting high growth expectations. Analyst sentiment is overwhelmingly positive, with a consensus price target of $572.54.
The outlook for SNPS is favorable, driven by AI integration and strategic acquisitions, but risks include high valuation sensitivity and competitive pressures. Revenue growth and margin expansion from new deals present opportunities, though investors should monitor execution risks and market volatility. The stock's proximity to key resistance levels suggests potential for near-term consolidation or breakout.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →
